Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a call for potential VBP pilots to be urgently identified. The UK’s Department of Health and Social Care has called for potential
After AbbVie announced the marketing authorisation from MHRA for ELAHERE, Med-Tech Insights spoke to the company to find out more. When do you anticipate mirvetuximab soravtansine will be available to eligible patients? Mirvetuximab soravtansine is now licensed as a monotherapy in the UK for the tre
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, records World Health Organization recognition for UK’s medical device regulator. The World Health Organization (WHO) has recognised the UK’s
In 1995 the FDA approved the first AI-enabled medical device, an automatic interactive gynaecological instrument to analyse Papanicolau (PAP) cervical smears. Although the FDA has been reviewing and authorising AI-enabled devices for 30 years, for most of that time these devices were a relative rari
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a new consultation launched by NICE. The National Institute for Health and Care Excellence (NICE) has launched a consultation see
With over 363,000 children waiting for consultant-led paediatric care in England last year alone, timely access to care remains a pressing challenge for the NHS. But beyond waiting lists, a quieter risk persists – outdated or non-compliant medical equipment still widely used in children’s wards acro
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on the MHRA’s new project to support innovative diagnostic MedTech. The Medicines and Healthcare products Regulatory Agency (MHRA) h
AbbVie has announced that it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult patients with folate receptor-alpha (FRα) positive, platinum-resistant h
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on the MHRA’s response to its recent public co
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on the publication of a new Social Value Playb
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on the launch of a stakeholder survey of MedTe
According to GlobalData, a leading data, and analytics company, a ‘bold’ 65.5 million AUD investment in biomedical and medtech from the Australian Government marks a strategic shift toward healthcare innovation and self-reliance in the country. By boosting domestic R&D and manufacturing, Australia a
